Humana Inc. (HUM) Sets New 52-Week Low at $150.00
Humana Inc. (NYSE:HUM) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $150.00 and last traded at $150.30, with a volume of 5,973,778 shares. The stock had previously closed at $159.64.
Several brokerages have recently issued reports on HUM. Jefferies Group upgraded Humana from a “hold” rating to a “buy” rating and raised their price objective for the stock from $158.89 to $210.00 in a research note on Monday. Cantor Fitzgerald restated a “buy” rating on shares of Humana in a research note on Saturday, July 9th. JPMorgan Chase & Co. cut Humana from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $196.00 to $150.00 in a research note on Friday, July 8th. Credit Suisse Group AG restated a “hold” rating on shares of Humana in a research note on Tuesday, June 28th. Finally, Wolfe Research began coverage on Humana in a research note on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 price objective for the company. One research analyst has rated the stock with a sell rating, seven have given a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $206.36.
The stock has a market cap of $22.68 billion and a PE ratio of 21.22. The stock has a 50 day moving average price of $178.17 and a 200 day moving average price of $174.65.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, May 4th. The insurance provider reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.81 by $0.05. The firm earned $13.80 billion during the quarter, compared to analyst estimates of $13.80 billion. During the same period last year, the company earned $2.58 earnings per share. The firm’s revenue for the quarter was down .2% compared to the same quarter last year. On average, equities research analysts predict that Humana Inc. will post $8.87 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Thursday, June 30th will be given a $0.29 dividend. The ex-dividend date is Tuesday, June 28th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.73%.
Several hedge funds have recently made changes to their positions in HUM. Wellington Shields Capital Management LLC boosted its stake in shares of Humana by 17.1% in the fourth quarter. Wellington Shields Capital Management LLC now owns 5,935 shares of the insurance provider’s stock worth $1,059,000 after buying an additional 865 shares during the period. Commerzbank Aktiengesellschaft FI increased its stake in Humana by 52.0% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 8,869 shares of the insurance provider’s stock valued at $1,583,000 after buying an additional 3,035 shares in the last quarter. Tredje AP fonden increased its stake in Humana by 1.7% in the fourth quarter. Tredje AP fonden now owns 9,477 shares of the insurance provider’s stock valued at $1,694,000 after buying an additional 158 shares in the last quarter. Gamco Investors INC. ET AL increased its stake in Humana by 12.1% in the fourth quarter. Gamco Investors INC. ET AL now owns 9,620 shares of the insurance provider’s stock valued at $1,717,000 after buying an additional 1,040 shares in the last quarter. Finally, Deere & Co. increased its stake in Humana by 791.1% in the fourth quarter. Deere & Co. now owns 10,078 shares of the insurance provider’s stock valued at $1,799,000 after buying an additional 8,947 shares in the last quarter.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.